HealthQuill type 2 diabetes
Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients 18 years or older, to the treatment regime.
Drugs Health Pharma

Regulator okays Insulet’s insulin pump in US to treat type 2 diabetes

Insulet Corporation, a tubeless insulin pump maker, got clearance from the US Food and Drug Administration to add diabetes type 2 adult patients.

Read More
AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according to a company statement.
Drugs Health Pharma

FDA approves AstraZeneca’s type-2 diabetes drug in US market

AstraZeneca’s oral drug to treat type-2 diabetes in patients aged 10 years and above has got approval from the US drug regulator, according.

Read More
Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24% of people involved in trials, the company announced.
Drugs Health Pharma

Novo Nordisk says Ozempic reduces kidney disease progression 

HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney death in 24%.

Read More
obesity
Drugs Health Medical

Ultra-Processed Foods linked to over 30 adverse health outcomes

Bharti Jayshankar February 29, 2024: From packaged snacks to sugary drinks, the allure of ultra-processed foods (UPF) has become a staple in many.

Read More
Cancer patients and survivors who drink alcohol make their treatment less effective and raise their chances of the disease returning — an exigency often ignored by caretakers.
Drugs Health Medical Pharma

Medications for obesity show promise in curbing alcohol cravings

Bharti Jayshankar January 26, 2024: A recent study has uncovered an unexpected benefit of medications commonly prescribed for obesity and type 2 diabetes:.

Read More
Drugs Health Medical Pharma

Metformin may prevent dementia in diabetics, new research suggests 


HQ Team October 27, 2023: Millions of individuals managing diabetes rely on metformin to regulate their blood sugar levels. Recent research highlights the.

Read More
The global population of people living with diabetes may more than double to 1.3 billion from the current 529 million in the next 30 years, according to researchers at the University of Washington.
Drugs Health Pharma

Global diabetic population may more than double by 2050

HQ Team June 23, 2023: The global population of people living with diabetes may more than double to 1.3 billion from the current.

Read More
Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to cancer spreading faster, according to a study by researchers at the University of Copenhagen.
Drugs Health Pharma

Cancer spreads faster when patient is insulin-resistant: Danish study

HQ Team June 21, 2023: Patients with cancer are markedly insulin-resistant, similar to people with type 2 diabetes, and it can lead to.

Read More
Diabetes
Drugs Health Medical

Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals

HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.

Read More
Cytokinetics, a US-based biopharmaceutical company, announced the FDA had rejected its new drug application for approving a trial drug to treat heart problems with reduced ejection fraction (HFrEF).
Drugs Health Pharma

FDA approves Lexicon’s oral drug for heart failure, type 2 diabetes patients

INPEFA is an inhibitor of both sodium-glucose co-transporter type 2 (SGLT2) and type 1 (SGLT1). This class of SGLT inhibitors was recommended as.

Read More
X